messaggio

clik on the image and visit the new site

New site clik on the image

"In silico"


From Wikipedia
If the target host* of a phage therapy treatment is not an animal the term "biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".

In silico
From:"Genomics,Proteomics and Clinical Bacteriology",N.Woodford and Alan P.Johnson

Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.


Phage Therapy is influenced by:

Phage therapy is influenced by:

Country : the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Temporariness
Mutation rate
Phenotypical delay
Phage cocktail

My point of view

Monday 13 April 2009

Phage Therapy Preparations



-Natural Phages or Natural mutant Phages

-Phages that are modified by genetic engineering

-Virolysins (phage-encoded lytic enzymes also called lysins or endolysins)


From
:
Recent Patents on Biotechnology 2009, 3, 000-000
"Production and Application of Bacteriophage and Bacteriophage-Encoded Lysins"
Noémie Manuelle Dorval Courchesne, Albert Parisien, Christopher Q. Lan
Department of Chemical and Biological Engineering, The University of Ottawa, Ottawa, ON, Canada K1N 6N5


".... it was reported that sub-lethal concentrations of certain antibiotics could substantially stimulate the host bacterial cell's production of virulent phages. For example, a low dosage of cefotaxime, a cephalosporin, increased an uropathogenic E.coli strain's production of the phage MFP by more than 7 fold. This phenomenon, which is designated as Phage Antibiotic Synergy (PAS), was observed in diverse hostphage systems. A common characteristic of these antibiotics is that they inhibit bacterial cell division and trigger the SOS system. The PAS phenomenon was found to be directly related to the formation of filamentous (elongated) cells under the stress of sub-lethal antibiotics. It was hypothesized that there has been an evolutionary selection for phages that can more efficiently cannibalize host cells that are unable to further divide. It was further suggested that if this is true, then the optimal conditions for phage multiplication may not be exponential cell growth as is widely believed, but rather a terminal burst of phage production in a stressed cell population that would soon die anyway. This observation provided the foundation for two recent patents exploiting the PAS phenomenon for enhanced phage production.

Applications of phages and virolysins include treatment and prevention of bacterial infections, detection of pathogens in foods and other samples, and decontamination of foods and medical devices.
Phages can also be utilized for
a diversity of other applications such as in targeted drug delivery and in preventing biofilm formation in industrial processes".